Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared a post on X:
“Axel Bex discussing the role of partial nephrectomy in renal cancer and highlighting difficulties in completing investigator-led studies.
While partial nephrectomy data looks better and is SOC, the detail of the largest trial (OPERA) shows it did not meet statistical significance.”
More posts featuring Tom Powles on OncoDaily.